Welch Allyn and ZOLL Medical Corporation announce strategic alliance

October 2008

Welch Allyn Inc. and ZOLL Medical Corporation (NASDAQGS: ZOLL) have entered into a strategic alliance regarding research and development, manufacturing, sales, service, and distribution relating to Welch Allyn’s defibrillation and monitoring products. The two companies have agreed to work together across multiple areas to capitalize on complementary strengths in each company’s operations and products.

Welch Allyn will continue to focus on sales of the Welch Allyn AED 10, a simple AED provided to alternate care markets, where the company is the leader in sales of equipment and products for physician office practices. It is anticipated that ZOLL will become the manufacturer and exclusive supplier of these defibrillator products to Welch Allyn. Sales and manufacturing of the PIC line of manual/conventional Welch Allyn defibrillators and the Welch Allyn AED 20 will be discontinued in the near future.

Welch Allyn has named ZOLL an exclusive distributor for the Propaq LT monitor for EMS in North America. The Propaq LT is a lightweight, highly portable and flexible monitor that displays multiple lead ECG, SPO2, non-invasive blood pressure, and respiration parameters. This product will be offered in conjunction with the ZOLL AED Pro that provides both semi-automatic and manual defibrillation capabilities, and incorporates ZOLL's Real CPR Help and See-Thru CPR to provide real-time feedback on CPR quality.

Welch Allyn and ZOLL will also be jointly pursuing business opportunities in the military portion of the monitoring and resuscitation markets, where both companies have leading positions with their current products, the Propaq monitor and the

ZOLL M Series Critical Care Transport defibrillator. Upon completion of certain milestones, it is anticipated that ZOLL will acquire Welch Allyn’s defibrillation research and development operations in Long Grove, Ill.

In the future, ZOLL will provide customer support and technical service and supply aftermarket accessories to Welch Allyn defibrillator customers.

“This partnership combines the strength of Welch Allyn’s leadership in portable monitoring with ZOLL Medical’s technical leadership in resuscitation to better serve EMS, military and air medical customers,” said Julie Shimer, President and CEO of Welch Allyn. “We have invested substantially in research and new product development in these areas, and our strategic alliance with ZOLL Medical will allow us to more effectively focus these efforts to best meet the needs of these markets while providing our customers with the very best products and service.”

Richard A. Packer, ZOLL Chairman and CEO, added, “While this strategic agreement with Welch Allyn will not have an immediate substantial impact on our business, we are excited about its future potential. We believe it will provide significant leverage to ZOLL's leadership position in resuscitation and will bring benefits to each company’s current and future customers. We look forward to talking about the whole arrangement in more detail on our next earnings call in November.”

It is expected that the elements of the strategic alliance will be implemented over the next several months.

Bookmark this page

Your browser does not support inline frames or is currently configured not to display inline frames.	Your browser does not support inline frames or is currently configured not to display inline frames. Welch Allyn and ZOLL Medical Corporation announce strategic alliance October 2008 Welch Allyn Inc. and ZOLL Medical Corporation (NASDAQGS: ZOLL) have entered into a strategic alliance regarding research and development, manufacturing, sales, service, and distribution relating to Welch Allyn’s defibrillation and monitoring products. The two companies have agreed to work together across multiple areas to capitalize on complementary strengths in each company’s operations and products. Welch Allyn will continue to focus on sales of the Welch Allyn AED 10, a simple AED provided to alternate care markets, where the company is the leader in sales of equipment and products for physician office practices. It is anticipated that ZOLL will become the manufacturer and exclusive supplier of these defibrillator products to Welch Allyn. Sales and manufacturing of the PIC line of manual/conventional Welch Allyn defibrillators and the Welch Allyn AED 20 will be discontinued in the near future. Welch Allyn has named ZOLL an exclusive distributor for the Propaq LT monitor for EMS in North America. The Propaq LT is a lightweight, highly portable and flexible monitor that displays multiple lead ECG, SPO2, non-invasive blood pressure, and respiration parameters. This product will be offered in conjunction with the ZOLL AED Pro that provides both semi-automatic and manual defibrillation capabilities, and incorporates ZOLL's Real CPR Help and See-Thru CPR to provide real-time feedback on CPR quality. Welch Allyn and ZOLL will also be jointly pursuing business opportunities in the military portion of the monitoring and resuscitation markets, where both companies have leading positions with their current products, the Propaq monitor and the ZOLL M Series Critical Care Transport defibrillator. Upon completion of certain milestones, it is anticipated that ZOLL will acquire Welch Allyn’s defibrillation research and development operations in Long Grove, Ill. In the future, ZOLL will provide customer support and technical service and supply aftermarket accessories to Welch Allyn defibrillator customers. “This partnership combines the strength of Welch Allyn’s leadership in portable monitoring with ZOLL Medical’s technical leadership in resuscitation to better serve EMS, military and air medical customers,” said Julie Shimer, President and CEO of Welch Allyn. “We have invested substantially in research and new product development in these areas, and our strategic alliance with ZOLL Medical will allow us to more effectively focus these efforts to best meet the needs of these markets while providing our customers with the very best products and service.” Richard A. Packer, ZOLL Chairman and CEO, added, “While this strategic agreement with Welch Allyn will not have an immediate substantial impact on our business, we are excited about its future potential. We believe it will provide significant leverage to ZOLL's leadership position in resuscitation and will bring benefits to each company’s current and future customers. We look forward to talking about the whole arrangement in more detail on our next earnings call in November.” It is expected that the elements of the strategic alliance will be implemented over the next several months. Bookmark this page Your browser does not support inline frames or is currently configured not to display inline frames. To top	Your browser does not support inline frames or is currently configured not to display inline frames.